Pd@Ir-LOD multienzyme utilizing endogenous lactate consumption cooperates with photothermal for tumor therapy

Ye, Zichen; Li, Yun; Li, Jingchao; Hu, Xinyan; Zheng, Jinyang; Gong-xin, Zhang; Xiang, Sijin; Zhu, Tianbao; Guo, Zhide; Chen, Xiaolan

doi:10.1007/s12274-023-5764-1

Cited by 5 publications

(1 citation statement)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the therapeutic efficacy of LOX is limited by rapid clearance, easy degradation or inactivation, off-target effects, and toxicity. To improve the stability of LOX and its enrichment in tumor sites, some nanosized carriers, such as MOF, [94,97] cationic liposomes, [91,98] MSN, [99] hydrogel, [100] noble metal, [101] protein nanoparticles, [102] etc., have been developed for tumor-targeted delivery of LOX. Nevertheless, the catalytic efficiency of LOX is greatly limited by the insufficient supply of O 2 at tumor sites.…”

Section: Natural Biological Enzyme-based Nanosystemsmentioning

confidence: 99%

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Cheng,

Shi,

et al. 2023

Advanced Science

View full text Add to dashboard Cite

Increasing numbers of studies have shown that tumor cells prefer fermentative glycolysis over oxidative phosphorylation to provide a vast amount of energy for fast proliferation even under oxygen‐sufficient conditions. This metabolic alteration not only favors tumor cell progression and metastasis but also increases lactate accumulation in solid tumors. In addition to serving as a byproduct of glycolytic tumor cells, lactate also plays a central role in the construction of acidic and immunosuppressive tumor microenvironment, resulting in therapeutic tolerance. Recently, targeted drug delivery and inherent therapeutic properties of nanomaterials have attracted great attention, and research on modulating lactate metabolism based on nanomaterials to enhance antitumor therapy has exploded. In this review, the advanced tumor therapy strategies based on nanomaterials that interfere with lactate metabolism are discussed, including inhibiting lactate anabolism, promoting lactate catabolism, and disrupting the “lactate shuttle”. Furthermore, recent advances in combining lactate metabolism modulation with other therapies, including chemotherapy, immunotherapy, photothermal therapy, and reactive oxygen species‐related therapies, etc., which have achieved cooperatively enhanced therapeutic outcomes, are summarized. Finally, foreseeable challenges and prospective developments are also reviewed for the future development of this field.

show abstract

Section: Natural Biological Enzyme-based Nanosystemsmentioning

confidence: 99%

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Cheng,

Shi,

et al. 2023

Advanced Science

View full text Add to dashboard Cite

show abstract

Catalytic Biomaterials‐Activated In Situ Chemical Reactions: Strategic Modulation and Enhanced Disease Treatment

Wang,

He,

Liao

et al. 2024

Advanced Materials

View full text Add to dashboard Cite

Chemical reactions underpin biological processes, and imbalances in critical biochemical pathways within organisms can lead to the onset of severe diseases. Within this context, the emerging field of “Nanocatalytic Medicine” leverages nanomaterials as catalysts to modulate fundamental chemical reactions specific to the microenvironments of diseases. This approach is designed to facilitate the targeted synthesis and localized accumulation of therapeutic agents, thus enhancing treatment efficacy and precision while simultaneously reducing systemic side effects. The effectiveness of these nanocatalytic strategies critically hinges on a profound understanding of chemical kinetics and the intricate interplay of reactions within particular pathological microenvironments to ensure targeted and effective catalytic actions. This review methodically explores in situ catalytic reactions and their associated biomaterials, emphasizing regulatory strategies that control therapeutic responses. Furthermore, the discussion encapsulates the crucial elements‐reactants, catalysts, and reaction conditions/environments‐necessary for optimizing the thermodynamics and kinetics of these reactions, while rigorously addressing both the biochemical and biophysical dimensions of the disease microenvironments to enhance therapeutic outcomes. It seeks to clarify the mechanisms underpinning catalytic biomaterials and evaluate their potential to revolutionize treatment strategies across various pathological conditions.

show abstract

Valence-tailored copper-based nanoparticles for enhanced chemodynamic therapy through prolonged ROS generation and potentiated GSH depletion

Li,

Ding,

et al. 2024

Nano Res.

View full text Add to dashboard Cite

Pd@Ir-LOD multienzyme utilizing endogenous lactate consumption cooperates with photothermal for tumor therapy

Cited by 5 publications

References 40 publications

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy

Catalytic Biomaterials‐Activated In Situ Chemical Reactions: Strategic Modulation and Enhanced Disease Treatment

Valence-tailored copper-based nanoparticles for enhanced chemodynamic therapy through prolonged ROS generation and potentiated GSH depletion

Contact Info

Product

Resources

About